Open

Registry of patients with EoE treated with Dupixent

The purpose of this study is to create a registry of patients with EoE that are being treated with Dupixent in their clinical care to collect data on outcomes of Dupixent treatment.

Age & Gender

12 years ~ 99 years
Male, Female, Gender Inclusive

Location

United States (Nationwide)

What will be asked of you

You will be asked to complete assessments prior to initiating treatment of Dupixent clinically for EoE. Every 3-6 months, you will be asked to complete assessments about your disease symptoms, severity, and impact on your life. These items can be done in-person or remotely.

Incentives

Up to $475

Total length of participation:
3 years

Looking for Specific Volunteers

Able to participate:

are diagnosed with Eosinophilic Esophagitis

Not eligible if:

Have already started treatment with Dupixient

Contact the Team

Visit Location

Julia Phillips

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Evan Dellon
Center for Gastrointestinal Biology and Disease

Study Type

Clinical or Medical
Registry

Study Topics

Stomach, Digestion and Gut Health
Ear, Nose, and Throat

IRB Number

24-2710

ClinicalTrials.gov

NCT06693531

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.